Inhibition of HSP90 in combination with radiotherapy for the treatment of p53-deficient cancers

被引：0
|
作者：
Seidl, K. [1 ]
Stegen, B. [1 ,2 ,3 ]
Schuster, J. [1 ]
Winssinger, N. [4 ]
Belka, C. [1 ,2 ,3 ]
Lauber, K. [1 ,2 ,3 ]
Orth, M. [1 ,2 ,3 ]
机构：
[1] Univ Hosp Munchen LMU, Radiat Oncol, Munich, Germany
[2] Partner Site Munchen, German Canc Consortium DKTK, Munich, Germany
[3] German Canc Res Ctr, Heidelberg, Germany
[4] Univ Geneva, Organ Chem, Geneva, Switzerland
来源：
STRAHLENTHERAPIE UND ONKOLOGIE | 2018年 / 194卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
V03-1
引用
收藏
页码：S11 / S11
页数：1
相关论文
共 50 条
  • [1] Inhibition of HSP90 in combination with radiotherapy for the treatment of p53-deficient cancers
    Seidl, K.
    Mutlu, S.
    Stegen, B.
    Schuster, J.
    Winssinger, N.
    Belka, C.
    Lauber, K.
    Orth, M.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2019, 195 : S168 - S168
  • [2] Preferential radiosensitization of p53-deficient tumor cells by HSP90 inhibition relies on impaired cell cycle adaptation
    Seidl, K.
    Belka, C.
    Lauber, K.
    Orth, M.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2014, 190 : 84 - 84
  • [3] TPRKB dependency in p53-deficient cancers
    VanDenBerg, Kelly
    Goswami, Moloy
    Wang, Lei Lucy
    Singh, Bhavneet
    Weiss, Travis
    Han, Sumin
    Rhodes, Dan
    Feng, Felix
    Tomlins, Scott
    CANCER RESEARCH, 2017, 77
  • [4] Chk'ing p53-deficient breast cancers
    Schoppy, David W.
    Brown, Eric J.
    JOURNAL OF CLINICAL INVESTIGATION, 2012, 122 (04): : 1202 - 1205
  • [5] Identification and Characterization of TPRKB Dependency in p53-Deficient Cancers
    Goswami, M. T.
    Kennaley, K. R.
    Han, S.
    Tomlins, S. A.
    Wang, L.
    Rhodes, D.
    Feng, F.
    Weiss, T.
    Singh, B.
    Barlow, M. W.
    Wilder-Romans, K.
    AMERICAN JOURNAL OF PATHOLOGY, 2018, 188 (10): : 2418 - 2418
  • [6] Inhibition of heat shock protein 90 (HSP90) as a therapeutic strategy for the treatment of myeloma and other cancers
    Richardson, Paul G.
    Mitsiades, Constantine S.
    Laubach, Jacob P.
    Lonial, Sagar
    Chanan-Khan, Asher A.
    Anderson, Kenneth C.
    BRITISH JOURNAL OF HAEMATOLOGY, 2011, 152 (04) : 367 - 379
  • [7] Evaluation of a novel two-drug combination strategy for p53-deficient colorectal and pancreatic cancers
    Alruwaili, Mohammed M.
    Zonneville, Justin
    Alqarni, Mohammed A.
    Rajan, Priyanka
    Serio, Hannah
    Straubinger, Robert
    Fountzilas, Christos
    Bakin, Andrei
    CANCER RESEARCH, 2023, 83 (07)
  • [8] p53反式结合hsp90β基因
    陈丽玲
    吴宁华
    沈珝琲
    关新民
    中国医学科学院学报, 2002, (03) : 285 - 288
  • [9] Hsp90 inhibition increases p53 expression and destabilizes MYCN and MYC in neuroblastoma
    Regan, Paul L.
    Jacobs, Joshua
    Wang, Gerald
    Torres, Jaime
    Edo, Robby
    Friedmann, Jennifer
    Tang, Xao X.
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2011, 38 (01) : 105 - 112
  • [10] Inhibition of MDM2 by hsp90 contributes to mutant p53 stabilization
    Peng, YH
    Chen, LH
    Li, CG
    Lu, WG
    Chen, JD
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (44) : 40583 - 40590
12345